McCabe LL, McCabe ER: Expanded newborn screening: implications for genomic medicine. Annu Rev Med. 2008, 59: 163-175. 10.1146/annurev.med.59.110106.132016.
Article
CAS
PubMed
Google Scholar
Teckman J, Perlmutter DH: Conceptual advances in the pathogenesis and treatment of childhood metabolic liver disease. Gastroenterology. 1995, 108: 1263-1279. 10.1016/0016-5085(95)90229-5.
Article
CAS
PubMed
Google Scholar
Toso C, Ris F, Mentha G, Oberholzer J, Morel P, Majno P: Potential impact of in situ liver splitting on the number of available grafts. Transplantation. 2002, 74: 222-226. 10.1097/00007890-200207270-00013.
Article
PubMed
Google Scholar
Newstead CG: Assessment of risk of cancer after renal transplantation. Lancet. 1998, 351: 610-611. 10.1016/S0140-6736(98)22009-5.
Article
CAS
PubMed
Google Scholar
Shneider BL: Pediatric liver transplantation in metabolic disease: clinical decision making. Pediatr Transplant. 2002, 6: 25-29. 10.1034/j.1399-3046.2002.1p057.x.
Article
PubMed
Google Scholar
Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, Wilson JM, Batshaw ML: Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab. 2003, 80: 148-158. 10.1016/j.ymgme.2003.08.016.
Article
CAS
PubMed
Google Scholar
Hacein-Bey-Abina S, von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M: LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003, 302: 415-419. 10.1126/science.1088547.
Article
CAS
PubMed
Google Scholar
Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis-Girod S, Fischer A, Davies EG, Kuis W, Leiva L, Cavazzana-Calvo M: Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med. 2002, 346: 1185-1193. 10.1056/NEJMoa012616.
Article
CAS
PubMed
Google Scholar
Ferry N, Duplessis O, Houssin D, Danos O, Heard JM: Retroviral-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci USA. 1991, 88: 8377-8381. 10.1073/pnas.88.19.8377.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman C, Finegold M, Thompson AR, Read MS, Brinkhous KM: In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science. 1993, 262: 117-119. 10.1126/science.8211118.
Article
CAS
PubMed
Google Scholar
Patijn GA, Lieber A, Schowalter DB, Schwall R, Kay MA: Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology. 1998, 28: 707-716. 10.1002/hep.510280317.
Article
CAS
PubMed
Google Scholar
VandenDriessche T, Vanslembrouck V, Goovaerts I, Zwinnen H, Vanderhaeghen ML, Collen D, Chuah M: Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice. Proc Natl Acad Sci USA. 1999, 96: 10379-10384. 10.1073/pnas.96.18.10379.
Article
PubMed Central
CAS
PubMed
Google Scholar
Xu L, Gao C, Sands MS, Cai SR, Nichols TC, Bellinger DA, Raymer RA, McCorquodale S, Ponder KP: Neonatal or hepatocyte growth factor-potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B. Blood. 2003, 101: 3924-3932. 10.1182/blood-2002-10-3050.
Article
CAS
PubMed
Google Scholar
Brunetti-Pierri N, Ng P: Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors. Gene Ther. 2008, 15: 553-560. 10.1038/gt.2008.14.
Article
PubMed Central
CAS
PubMed
Google Scholar
Brunetti-Pierri N, Palmer DJ, Beaudet AL, Carey KD, Finegold M, Ng P: Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum Gene Ther. 2004, 15: 35-46. 10.1089/10430340460732445.
Article
CAS
PubMed
Google Scholar
Raper SE, Yudkoff M, Chirmule N, Gao GP, Nunes F, Haskal ZJ, Furth EE, Propert KJ, Robinson MB, Magosin S, Simoes H, Speicher L, Hughes J, Tazelaar J, Wivel NA, Wilson JM, Batshaw ML: A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum Gene Ther. 2002, 13: 163-175. 10.1089/10430340152712719.
Article
CAS
PubMed
Google Scholar
Seiler MP, Cerullo V, Lee B: Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects. Curr Gene Ther. 2007, 7: 297-305. 10.2174/156652307782151452.
Article
CAS
PubMed
Google Scholar
Brunetti-Pierri N, Stapleton GE, Palmer DJ, Zuo Y, Mane VP, Finegold MJ, Beaudet AL, Leland MM, Mullins CE, Ng P: Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy. Mol Ther. 2007, 15: 732-740.
CAS
PubMed
Google Scholar
Mok H, Palmer DJ, Ng P, Barry MA: Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol Ther. 2005, 11: 66-79. 10.1016/j.ymthe.2004.09.015.
Article
CAS
PubMed
Google Scholar
Croyle MA, Le HT, Linse KD, Cerullo V, Toietta G, Beaudet A, Pastore L: PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile. Gene Ther. 2005, 12: 579-587. 10.1038/sj.gt.3302441.
Article
CAS
PubMed
Google Scholar
Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM: Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA. 2002, 99: 11854-11859. 10.1073/pnas.182412299.
Article
PubMed Central
CAS
PubMed
Google Scholar
Allocca M, Doria M, Petrillo M, Colella P, Garcia-Hoyos M, Gibbs D, Kim SR, Maguire A, Rex TS, Di Vicino U, Cutillo L, Sparrow JR, Williams DS, Bennett J, Auricchio A: Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J Clin Invest. 2008, 118: 1955-1964. 10.1172/JCI34316.
Article
PubMed Central
CAS
PubMed
Google Scholar
Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, Ozelo MC, Hoots K, Blatt P, Konkle B, Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Rustagi PK, Nakai H, Chew A, Leonard D, Wright JF, Lessard RR, Sommer JM, Tigges M, Sabatino D, Luk A, Jiang H, Mingozzi F, Couto L, Ertl HC, High KA, Kay MA: Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med. 2006, 12: 342-347. 10.1038/nm1358.
Article
CAS
PubMed
Google Scholar
Mingozzi F, Maus MV, Hui DJ, Sabatino DE, Murphy SL, Rasko JE, Ragni MV, Manno CS, Sommer J, Jiang H, Pierce GF, Ertl HC, High KA: CD8(+) T-cell responses to adeno-associated virus capsid in humans. Nat Med. 2007, 13: 419-422. 10.1038/nm1549.
Article
CAS
PubMed
Google Scholar
Nakai H, Yant SR, Storm TA, Fuess S, Meuse L, Kay MA: Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J Virol. 2001, 75: 6969-6976. 10.1128/JVI.75.15.6969-6976.2001.
Article
PubMed Central
CAS
PubMed
Google Scholar
Donsante A, Vogler C, Muzyczka N, Crawford JM, Barker J, Flotte T, Campbell-Thompson M, Daly T, Sands MS: Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Gene Ther. 2001, 8: 1343-1346. 10.1038/sj.gt.3301541.
Article
CAS
PubMed
Google Scholar
Donsante A, Miller DG, Li Y, Vogler C, Brunt EM, Russell DW, Sands MS: AAV vector integration sites in mouse hepatocellular carcinoma. Science. 2007, 317: 477-10.1126/science.1142658.
Article
CAS
PubMed
Google Scholar
Hasbrouck NC, High KA: AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects. Gene Ther. 2008, 15: 870-875. 10.1038/gt.2008.71.
Article
CAS
PubMed
Google Scholar
Niidome T, Huang L: Gene therapy progress and prospects: nonviral vectors. Gene Ther. 2002, 9: 1647-1652. 10.1038/sj.gt.3301923.
Article
CAS
PubMed
Google Scholar
Liu F, Song Y, Liu D: Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999, 6: 1258-1266. 10.1038/sj.gt.3300947.
Article
CAS
PubMed
Google Scholar
Zhang G, Budker V, Wolff JA: High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther. 1999, 10: 1735-1737. 10.1089/10430349950017734.
Article
CAS
PubMed
Google Scholar
Eastman SJ, Baskin KM, Hodges BL, Chu Q, Gates A, Dreusicke R, Anderson S, Scheule RK: Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum Gene Ther. 2002, 13: 2065-2077. 10.1089/10430340260395910.
Article
CAS
PubMed
Google Scholar
Alino SF, Herrero MJ, Noguera I, Dasi F, Sanchez M: Pig liver gene therapy by noninvasive interventionist catheterism. Gene Ther. 2007, 14: 334-343. 10.1038/sj.gt.3302873.
Article
CAS
PubMed
Google Scholar
Strauss KA, Robinson DL, Vreman HJ, Puffenberger EG, Hart G, Morton DH: Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease. Eur J Pediatr. 2006, 165: 306-319. 10.1007/s00431-005-0055-2.
Article
PubMed
Google Scholar
Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, Dorko K, Sauter BV, Strom SC: Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med. 1998, 338: 1422-1426. 10.1056/NEJM199805143382004.
Article
CAS
PubMed
Google Scholar
Jia Z, Danko I: Long-term correction of hyperbilirubinemia in the Gunn rat by repeated intravenous delivery of naked plasmid DNA into muscle. Mol Ther. 2005, 12: 860-866. 10.1016/j.ymthe.2005.04.023.
Article
CAS
PubMed
Google Scholar
Bellodi-Privato M, Aubert D, Pichard V, Myara A, Trivin F, Ferry N: Successful gene therapy of the Gunn rat by in vivo neonatal hepatic gene transfer using murine oncoretroviral vectors. Hepatology. 2005, 42: 431-438. 10.1002/hep.20794.
Article
CAS
PubMed
Google Scholar
Tada K, Chowdhury NR, Neufeld D, Bosma PJ, Heard M, Prasad VR, Chowdhury JR: Long-term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo. Liver Transpl Surg. 1998, 4: 78-88. 10.1002/lt.500040111.
Article
CAS
PubMed
Google Scholar
Wegen van der P, Louwen R, Imam AM, Buijs-Offerman RM, Sinaasappel M, Grosveld F, Scholte BJ: Successful treatment of UGT1A1 deficiency in a rat model of Crigler-Najjar disease by intravenous administration of a liver-specific lentiviral vector. Mol Ther. 2006, 13: 374-381. 10.1016/j.ymthe.2005.09.022.
Article
PubMed
Google Scholar
Toietta G, Mane VP, Norona WS, Finegold MJ, Ng P, McDonagh AF, Beaudet AL, Lee B: Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci USA. 2005, 102: 3930-3935. 10.1073/pnas.0500930102.
Article
PubMed Central
CAS
PubMed
Google Scholar
Seppen J, Bakker C, de Jong B, Kunne C, Oever van den K, Vandenberghe K, de Waart R, Twisk J, Bosma P: Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats. Mol Ther. 2006, 13: 1085-1092. 10.1016/j.ymthe.2006.01.014.
Article
CAS
PubMed
Google Scholar
Jia Z, Danko I: Single hepatic venous injection of liver-specific naked plasmid vector expressing human UGT1A1 leads to long-term correction of hyperbilirubinemia and prevention of chronic bilirubin toxicity in Gunn rats. Hum Gene Ther. 2005, 16: 985-995. 10.1089/hum.2005.16.985.
Article
CAS
PubMed
Google Scholar
Maestri NE, Clissold D, Brusilow SW: Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis. J Pediatr. 1999, 134: 268-272. 10.1016/S0022-3476(99)70448-8.
Article
CAS
PubMed
Google Scholar
Bachmann C: Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Eur J Pediatr. 2003, 162: 410-416. 10.1007/s00431-003-1347-z.
Article
PubMed
Google Scholar
Ye X, Robinson MB, Batshaw ML, Furth EE, Smith I, Wilson JM: Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors. J Biol Chem. 1996, 271: 3639-3646. 10.1074/jbc.271.7.3639.
Article
CAS
PubMed
Google Scholar
Mian A, McCormack WM, Mane V, Kleppe S, Ng P, Finegold M, O'Brien WE, Rodgers JR, Beaudet AL, Lee B: Long-term correction of ornithine transcarbamylase deficiency by WPRE-mediated overexpression using a helper-dependent adenovirus. Mol Ther. 2004, 10: 492-499. 10.1016/j.ymthe.2004.05.036.
Article
CAS
PubMed
Google Scholar
Brunetti-Pierri N, Clarke C, Mane V, Palmer DJ, Lanpher B, Sun Q, O' Brien W, Lee B: Phenotypic correction of ornithine transcarbamylase deficiency using low dose helper-dependent adenoviral vectors. J Gene Med. 2008, 10: 890-896. 10.1002/jgm.1218.
Article
PubMed Central
CAS
PubMed
Google Scholar
Moscioni D, Morizono H, McCarter RJ, Stern A, Cabrera-Luque J, Hoang A, Sanmiguel J, Wu D, Bell P, Gao GP, Raper SE, Wilson JM, Batshaw ML: Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors. Mol Ther. 2006, 14: 25-33. 10.1016/j.ymthe.2006.03.009.
Article
CAS
PubMed
Google Scholar